Causal Identification: Why Longitudinal Data Still Need a Design
Anas H. Alzahrani, MD PhD MPH
Department of Preventive Medicine and Public Health
Faculty of Medicine, King Abdulaziz University
Causal identification is not created by putting observations in date order. Longitudinal clinical data can show that treatment was recorded before an outcome, describe change, and reveal treatment-confounder feedback. Those are real advantages. But a timeline does not explain why treated and untreated patients were comparable, why follow-up remained representative, or why the measured contrast equals the effect the paper claims.
That distinction matters because “prospective,” “longitudinal,” and “time series” often receive causal credit they have not earned. Meanwhile, a repeated cross-section around a credible policy change or a single assessment near a treatment threshold may contain stronger causal leverage. The hierarchy is not cross-sectional below longitudinal. It is unclear comparison below credible comparison.
The Clean Metaphor: A Timeline Is a Ruler, Not a Randomizer
A timeline measures order. It does not manufacture exchangeability.
Knowing that A came before B is necessary for saying A caused B. It is not sufficient. The missing question is why the outcome under one exposure can stand in for the counterfactual outcome under the other.
Interactive causal-claim audit
Five Questions Before You Trust “Longitudinal”
Read a manuscript’s methods and mark each link. This is a reporting and reasoning screen, not a numeric risk-of-bias score.
Claim ceiling
Causal claim not yet auditable
The paper may eventually support a qualified causal claim, but the current report leaves one or more identification links implicit.
0 supported · 5 unclear · 0 absent
What Repeated Measurement Actually Adds
Longitudinal data can establish measurement order, distinguish incident from prevalent outcomes, estimate change, and show how exposure, prognosis, and treatment decisions evolve. Repeated measures may also supply the history required for g-methods when time-varying confounders both predict later treatment and are affected by earlier treatment. None of that is trivial.
But information and identification are different jobs. More measurements can reveal selective attrition without fixing it. They can record a time-varying confounder without making ordinary adjustment valid. They can show a lagged association without ruling out a common cause. The data may contain what a credible analysis needs while the actual analysis still fails to use it correctly.
| Temporal feature | What it can add | What it cannot prove |
|---|---|---|
| Exposure before outcome | Relevant measurement order | Absence of confounding or reverse causation through treatment choice |
| Repeated outcomes | Change and trajectory | A credible untreated counterfactual trajectory |
| Repeated covariates | Treatment-confounder history | That standard regression handles feedback correctly |
| Repeated follow-up | Observation of attrition | That those retained represent those lost |
Clinical Example: A Prospective Cohort Can Still Compare Prognosis
Consider a prospective registry of patients hospitalized with heart failure. Clinicians intensify a therapy during admission, and the study compares 12-month readmission between intensified and non-intensified groups. Treatment is documented before follow-up begins. The outcome is prospective. The temporal sequence is clear.
Yet clinicians may intensify therapy in patients who appear most stable, have better kidney function, or are more likely to adhere. They may withhold it from patients with frailty or hypotension. Without a defensible strategy for comparing patients at the same decision point with adequate measurement of the reasons for treatment, the study may estimate prognosis after a clinical decision rather than the causal effect of that decision.
Reviewer move
Replace “the prospective design supports causality” with a specific account: define the treatment strategy and time zero, explain the source of comparability, name the required assumptions, align the analysis, and show diagnostics aimed at the largest remaining threat.
Why Some Non-Longitudinal Designs Can Carry Causal Leverage
A regression discontinuity study may compare patients immediately above and below a treatment threshold. A policy evaluation may use repeated cross-sections before and after a change with a credible comparison trend. An instrumental-variable analysis may exploit an external source of treatment variation. These designs do not become credible because they use fewer or more waves. Their leverage comes from an assignment rule, threshold, policy timing, instrument, or adjustment strategy plus the assumptions that make that comparison informative.
The reverse warning also holds. Adding patient fixed effects, lagged variables, or a structural equation model does not automatically convert temporal association into intervention effects. Good model fit concerns how well a statistical structure reproduces observed data. Causal identification concerns what would have happened under a different exposure or treatment strategy.
Write the Limitation That Names the Failure
“The cross-sectional design prevents causal inference” is cautious but diagnostically thin. Is the problem concurrent measurement, reverse causation, residual confounding, selection, prevalent rather than incident disease, or exposure measured outside the etiologic period? A useful limitation names the operative threat and explains how it could bend the result.
The same standard applies to longitudinal work. If exposure precedes outcome but the groups may differ in baseline risk and retention is selective, say exactly that. If a qualified causal interpretation is intended, state the target effect and the assumptions under which the estimate receives that meaning. Causal language should be conditional on design logic, not awarded by the calendar.
Reviewer Red-Flag Checklist
Why This Matters for Aqrab
Identification logic rarely lives in one paragraph. The claimed effect may sit in the abstract, the treatment rule in a supplement, time zero in a cohort diagram, confounder reasoning in a table, and diagnostics across several figures. A useful methodology critique reconnects those pieces and tests whether they form one coherent causal argument.
Use Aqrab Try to pressure-test a paper’s causal claim. Start with the five questions above. The sharper prompt is not “Was the study longitudinal?” but “What, exactly, identifies the effect?”
Methods Sources
- Azagba S, de Silva GSR. Temporal Data Structure Is Not Causal Identification: A Practical Framework for Appraising Causal Claims in Prevention and Population Health Research. Journal of Prevention. Published online August 28, 2026. doi:10.1007/s10935-026-00948-0.
- Hernán MA, Robins JM. Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available. American Journal of Epidemiology. 2016;183(8):758–764.
- Savitz DA, Wellenius GA. Can Cross-Sectional Studies Contribute to Causal Inference? It Depends. American Journal of Epidemiology. 2023;192(4):514–516.
- Loh WW, Ren D. The Unfulfilled Promise of Longitudinal Designs for Causal Inference. Collabra: Psychology. 2023;9(1):89142.
- Greenland S, Pearl J, Robins JM. Causal Diagrams for Epidemiologic Research. Epidemiology. 1999;10(1):37–48.
Keep reading
Don't stop at one method.
Good methods judgment comes from contrast. Read the neighboring guides, see where the assumptions diverge, and avoid treating every observational problem like it needs the same hammer.
Before the Model: A Five-Gate Study Design Audit for Clinical Research
A practical five-gate study design audit for clinical researchers. Check the question, population, comparison, measurement, and follow-up before a sophisticated model gives a fragile design false confidence.
Causal Readiness: When a Huge Linked Dataset Still Cannot Identify an Effect
A practical guide to causal readiness in linked health and administrative data. Learn why scale and propensity-score overlap are not enough when treatment, need, comparators, or outcomes are poorly measured.
Triangulation in Clinical Research: When One Elegant Design Still Leaves the Same Blind Spot
A practical guide to triangulation in clinical research. Covers what counts as genuinely complementary evidence, how to map designs to specific threats, and what reviewers should demand before trusting “robustness” claims.